The market in Asia-Pacific is characterized by a mix of established pharmaceutical companies and emerging local players offering a range of treatment options, including medications, surgical procedures, and laser therapy. While traditional medications such as beta-blockers and prostaglandin analogs remain popular, there is a growing interest in innovative treatments such as minimally invasive...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian